No Pharma Money
News & Reports
News September 30, 2019

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

Slow news week.

1. Fear-mongering: Activate!

  • The drug lobby is throwing mounds of cash around in an attempt to convince lawmakers that drug pricing’s status quo should remain. Voters disagree! — (Wall Street Journal)

2. Four Times More

  • The latest investigation from Congress shows the U.S. pays an average of four times more for prescription drugs as compared to other countries — and in some cases, 67 times more. — (The Fiscal Times)

3. Black Market Insulin

  • Virginia patient explains the choice she was forced to make to stay alive. — (Local12)

4. Myth Busted

  • Pharma’s biggest talking point — lower prices will kill innovation — is debunked once again. — (STAT)

5. ?? imports?

  • The Trump administration announced it’s on track to release an executive order to import some prescription drugs. — (The Washington Post)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.